ACUTE LIVER FAILURE
Clinical trials for ACUTE LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new ACUTE LIVER FAILURE trials appear
Sign up with your email to follow new studies for ACUTE LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race against time: testing Blood-Cleaning treatments to save Children's livers
Disease control Recruiting nowThis study is testing two different amounts of plasma exchange (a blood-cleaning treatment) to see which one better helps children survive sudden, severe liver failure with their own liver. Doctors will compare a standard volume treatment to a high-volume treatment in 40 children…
Matched conditions: ACUTE LIVER FAILURE
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Race to save young livers: can immune drugs stop sudden failure?
Disease control Recruiting nowThis study is testing if two different immune-suppressing medications can help children survive a sudden, life-threatening liver failure without needing a transplant. About 160 children, aged 1 to 18, will be randomly assigned to receive one of the two drugs or standard supportiv…
Matched conditions: ACUTE LIVER FAILURE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Blood-Filtering machine tested as bridge to liver transplant
Disease control Recruiting nowThis study is testing a two-part blood-cleansing system for adults hospitalized with sudden, severe liver failure. The goal is to see if this artificial liver support can stabilize patients' organ function and blood clotting, helping them survive long enough for their own liver t…
Matched conditions: ACUTE LIVER FAILURE
Phase: NA • Sponsor: Institute for Clinical and Experimental Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug trial aims to rescue failing livers
Disease control Recruiting nowThis study is testing a new drug called F573 for people with serious liver injury or failure. It aims to see if the drug is safe and can help control liver damage. About 97 participants will receive either the drug or a placebo injection daily for up to 28 days, along with standa…
Matched conditions: ACUTE LIVER FAILURE
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Massive registry launched to track 'Blood Cleaner' in Real-World ICU use
Knowledge-focused Recruiting nowThis study is creating a large international registry to collect real-world data on how a medical device called CytoSorb is used in critical care. The device filters harmful substances from a patient's blood and is used for various severe conditions like septic shock, severe trau…
Matched conditions: ACUTE LIVER FAILURE
Sponsor: CytoSorbents, Inc • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC